Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
6th January 2021 | Capital, Llc Armistice | 1,531,101 | Open or private purchase | $5.23 | $8,000,002.73 |
6th January 2021 | Capital, Llc Armistice | 0 | Open or private purchase | $0.00 | |
10th December 2020 | Christopher Ryan Sullivan | 5,095 | Open or private purchase | $2.28 | $11,606.41 |
10th December 2020 | James Archie Jr Harrell | 171 | Open or private purchase | $2.28 | $389.54 |
10th December 2020 | Garry Arthur Neil | 3,599 | Open or private purchase | $2.28 | $8,198.52 |
4th December 2020 | Capital, Llc Armistice | 5,400 | Open or private purchase | $4.13 | $22,302.00 |
4th December 2020 | Capital, Llc Armistice | 0 | Open or private purchase | $0.00 | |
3rd December 2020 | Capital, Llc Armistice | 20,000 | Open or private purchase | $2.44 | $48,800.00 |
3rd December 2020 | Capital, Llc Armistice | 0 | Open or private purchase | $0.00 | |
2nd December 2020 | Capital, Llc Armistice | 1,000 | Open or private purchase | $4.31 | $4,310.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Cerecor, Inc. is a clinical stage biopharmaceutical company focuses in medical development. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.